The Agency for Healthcare Research and Quality seeks input through Nov. 12 on scientific evidence to inform a systematic review of telehealth use during COVID-19. Topics include the characteristics of patients and providers using telehealth and how they differ from before the pandemic; benefits and potential harms of telehealth use; successful telehealth strategies; and cost and reimbursement considerations. For more on the study by AHRQ’s Evidence-based Practice Centers Program, click here

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health May 16 passed a number of bills during a markup session, including AHA-supported legislation. The…
Headline
AHA submitted a statement May 8 to the House Ways and Means Committee for a markup session on proposed legislation impacting telehealth access for patients and…
Headline
In a letter submitted May 7 to a bipartisan group of senators, AHA urged Congress to extend the Affordable Connectivity Program, which provides benefits toward…
Headline
Sen. John Thune, R-S.D., April 16 updated AHA members on progress to extend telehealth waivers, offering hope that a solution will arise in end-of-year…
Headline
Rep. Morgan Griffith, R-Va., touted the benefits of telehealth April 15, saying it is uncovering hidden health care savings by encouraging patients to seek…
Headline
The Department of Health and Human Services’ revised “bulletin” for HIPAA covered entities and business associates using online tracking technologies only…